Genetic epidemiology of hepatitis C virus throughout Egypt

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 698-707

  Ray, Stuart C ^a   Arthur, Ray R ^a   Carella, Anthony ^a   Bukh, Jens ^b   Thomas, David L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EGYPT; GENETIC ANALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; VIRUS ISOLATION;

BLOOD DONORS; EGYPT; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA REPLICASE; SEROEPIDEMIOLOGIC STUDIES; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033831605     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315786     Document Type: Article

References (75)

1. Hepatitis C: Global prevalence
2. The natural history of community acquired hepatitis C in the United States
3. Interrelationship of blood transfusion, non-A, non-B hepatitis, and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
4. Clinical outcomes after transfusion-associated hepatitis C
5. Epidemiology of hepatitis C
6. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors
7. High HCV prevalence in Egyptian blood donors
8. High seroprevalence of hepatitis C infection among risk groups in Egypt
9. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors
10. High prevalence of hepatitis C in Egyptian patients with chronic liver disease
11. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children
12. A high risk of hepatitis C infection among Egyptian blood donors: The role of parenteral drug abuse
13. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women
14. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: Association of hepatitis C virus infections with specific regions of Egypt
15. Parenteral antischistosomal therapy: A potential risk factor for hepatitis B infection
16. HCV in Egypt in 1977
17. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
18. Does schistosomiasis play a role in the high seroprevalence of HCV antibody among Egyptians?
19. The epidemiology of Schistosoma mansoni, hepatitis B, and hepatitis C infection in Egypt
20. Chronic liver disease in the Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections
21. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
22. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide
23. Sequence analysis of the core gene of 14 hepatitis C virus genotypes
24. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
25. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
26. Typing of hepatitis C virus genomes by restriction fragment length polymorphism
27. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
28. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
29. Serological reactivity and viral genotypes in hepatitis C virus infection
30. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: Relationship to genotypes of hepatitis C virus
31. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
32. Molecular heterogeneity and new subtypes of HCV genotype 4
33. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes
34. A proposed system for the nomenclature of hepatitis C viral genotypes
35. Transmission of hepatitis C virus from mothers to infants
36. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: An analysis of 309 sex partnerships
37. Patient-to-patient transmission of hepatitis C virus during colonoscopy
38. High rate of hepatitis C virus infection in an isolated community: Persistent hyperendemicity or period-related phenomena?
39. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt
40. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays: Justification and rational implementation
41. Evaluation of the need for RIBA confirmation of second generation ELISA HCV antibody results
42. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
43. Genetic organization and diversity of the hepatitis C virus
44. There are two major types of hepatitis C virus in Japan
45. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey
46. Distribution of genotypes in the 5' untranslated region of hepatitis C virus in Korea
47. PHYLIP: Phylogeny inference package (version 3.2)
48. The origin of hepatitis C virus genotypes
49. Confidence limits on phylogenies: An approach using the bootstrap
50. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions
51. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
52. Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples
53. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease
54. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions
55. Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBEI) and the 2c-specific PCR primers
56. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes
57. Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C
58. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East
59. HCV infection in a rural population of the Central African Republic (CAR): Evidence for three additional subtypes of genotype 4
60. The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups
61. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa
62. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a
63. Sequence analysis of the 5' noncoding region of hepatitis C virus
64. A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation
65. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
66. Sequence variability in the 5' noncoding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity
67. Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: Application to isolates from Egyptian and Yemeni patients
68. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1, and NS-5 regions
69. Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences
70. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
71. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability
72. Limitations of a molecular clock applied to considerations of the origin of HIV-1
73. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort